top of page

Vicore Pharma's CEO describes the rationale for using angiotensin II type 2 receptor agonists in IPF

  • Sep 19, 2024
  • 1 min read

Ahmed Mousa describes what excited him to join the company from the U.S. one year ago, the unmet need that still exists in this large market, and what the path ahead is for the company's lead asset.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page